Data as of November 4, 2026
Dolobid 250 mg Tablet
DIFLUNISAL
Brand: Dolobid
Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.
Price per fill
NADAC (acquisition)
$1,580.39/ fill$20.63 / EA
Medicaid FFS
$2,911.83/ fill
Sources: cms/nadac:price-ladder · cms/sdud
What's in the reimbursement
Ingredient cost (76.6 units/fill)$1,580.39
Dispensing fee & other (state-fixed, not margin)$1,331.44
Total reimbursed per fill$2,911.83
The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.
Medicaid volume backing this card: 3 fee-for-service states, 0 managed-care states.
Full methodology and source columns: /tools/drug-prices/methodology